U.S. market Closed. Opens in 56 minutes

MRKR | Marker Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Revenue3.31M9.00M1.24M466.79K213.19K205.99KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A25.05K120.72K
Cost of Revenue10.42M3.68M3.16M18.88M12.76MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.63K38.60K
Gross Profit-7.11M5.32M-1.92M-18.41M-12.55M205.99KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A22.42K82.12K
Operating Expenses7.48M38.96M40.72M29.35M22.74M148.38M11.66M8.26M6.16M3.37M2.66M5.48M2.64M3.94M4.19M1.50M2.51M888.25K989.56K2.68M5.78M2.28M379.86K1.49M1.15M
Selling, General & Admin7.48M12.82M12.92M10.47M9.98M24.38M6.41M4.69M4.45M3.18M2.00M4.42M2.43M3.65M4.10M1.31M2.08M708.71K593.67K1.61M4.01M1.41M379.86K1.13M834.02K
Research & Development10.42M26.14M27.79M18.88M12.76M124.00M5.25M3.80M1.71M189.00K661.63K1.06M203.72K290.05K93.04K182.34K425.57K173.17K248.36K1.04M1.73M833.59KN/A341.19K294.92K
Other Operating ExpensesN/A-232.97K-2.41MN/AN/A116.05MN/A-231.20KN/AN/AN/AN/AN/AN/A3.74K7.48K5.97K6.37K147.53K37.45K42.37K40.77KN/A20.64K17.70K
Operating Income-14.58M-29.95M-39.48M-28.89M-22.53M-148.17M-11.66M-8.26M-6.16M-3.37M-2.66M-5.48M-2.64M-3.94M-4.19M-1.50M-2.51M-888.25K-989.56K-2.68M-5.78M-2.28M-379.86K-1.47M-1.06M
Other Expenses / Income539.16K15.09K-2.40M179.74K1.10M-40.00K497.87K5.81M-27.91M-27.51M-2.87M-380.22K607.92K-1.15M917.59K82.66KN/A30.46KN/AN/AN/AN/AN/A175.56K-62.80K
Before Tax Income-14.04M-29.93M-41.88M-28.71M-21.43M-147.96M-10.98M-2.46M-34.07M-30.88M-5.53M-5.86M-2.03M-5.09MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses3.67K-15.09K-5.70K-179.74K-1.10M-213.72KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-14.05M-29.92M-41.87M-28.53M-20.33M-147.96M-10.98M-2.46M-34.07M-30.88M-5.53M-5.86M-2.03M-5.09M-4.46M-2.20M-3.89M-1.30M-989.56K-2.68M-5.78M-2.28M-384.54K-1.29M-1.13M
Interest ExpensesN/A-15.09KN/AN/AN/AN/AN/AN/A10.93K575.54K1.76M745.07K679.33K1.24M1.19M778.18K1.38M446.60K116.82KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding8.81M8.35M7.65M4.70M4.56M1.91M945.35K6.89M3.66M1.29M94.67K54.60K38.33K33.17K16.42K1.99K1.73K1.73K1.73K1.73K1.73K1.73K1.73K1.73K1.73K
Diluted Shares Outstanding8.81M8.35M7.65M4.70M4.56M1.91M945.35K7.42M3.66M1.29M94.67K54.60K38.33K33.17K16.42K1.99K1.73K1.73K1.73K1.73K1.73K1.73K1.73K1.73K1.73K
EBITDA-11.79M-26.27M-36.32M-27.84M-22.26M-148.13M-10.98M-8.26M-6.16M-3.37M-2.66M-5.58M-2.64M-3.94M-4.19M-1.49M-2.51M-881.88K-958.85K-2.65M-5.74M-2.24M-379.86K-1.27M-1.11M
EBITDA Margin-356.14%-291.69%-2,924.62%-5,964.44%-10,441.30%-71,910.65%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-5,074.43%-919.21%
EBIT-14.04M-29.95M-41.88M-28.71M-21.43M-148.17M-10.98M-2.46M-34.06M-30.31M-3.78M-5.11M-1.35M-3.85M-3.27M-1.42M-2.51M-857.79K-872.74K-2.68M-5.78M-2.28M-384.54K-1.29M-1.13M
EBIT Margin-424.09%-332.56%-3,372.68%-6,149.74%-10,050.92%-71,930.07%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-5,156.80%-933.87%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙